HOUSTON, Sept. 11 /PRNewswire-FirstCall/ -- Cyberonics, Inc.
(Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive
Officer, and Greg Browne, Vice President, Finance and Chief Financial Officer,
will present at the UBS Global Life Sciences Conference in New York on
Wednesday, September 24, 2008 at 8:30 AM EDT. Presentation slides will be
available on-line at http://www.cyberonics.com by 5:00 PM EDT on Tuesday,
September 23, 2008. UBS will host a webcast of the presentation live and by
replay at http://www.ibb.ubs.com. The replay will be available approximately
three hours after the completion of the live presentation and until October
25, 2008. The presentation can also be accessed at http://www.cyberonics.com
by clicking on the link for this webcast. Access to the webcast is not
password protected.
ABOUT VNS THERAPY AND CYBERONICS
Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core
expertise in neuromodulation. The company developed and markets the Vagus
Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the
treatments of refractory epilepsy and depression. The VNS Therapy System uses
a surgically implanted medical device that delivers pulsed electrical signals
to the vagus nerve. Cyberonics markets the VNS Therapy System in selected
markets worldwide.
Additional information on Cyberonics, Inc. and VNS Therapy(TM) is
available at http://www.cyberonics.com and http://www.vnstherapy.com.
CONTACT INFORMATION:
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332
ir@cyberonics.com
SOURCE Cyberonics, Inc.
